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A differential serological screen of a Xgtll cDNA expression library of Plasmodiumfalciparum was performed
in an attempt to identify novel and putative host-protective antigens of the parasite. The screening was done
with two categories of sera: (i) acute-phase sera obtained from smear-positive acutely infected P. falciparum
patients from various regions in India and (ii) immune sera taken from healthy, permanent adult residents of
P.falciparum-endemic rural districts of Orissa in eastern India. These adults had not suffered from any clinical
malarial symptoms for at least the previous 3 years at the time of serum collection. Sixty-five clones obtained
by screening the Xgtll library with two immune serum samples were analyzed extensively with a total of 70
acutely infected patient serum samples. Eight of these clones failed to react with any of the patient sera. Each
of these eight clones, when tested individually with 92 serum samples from the immune group, reacted with a
minimum of 43% of the samples from this category of sera. Thus, these eight epitopes may encode
host-protective elements since they are not recognized by antibodies in the patient sera but react exclusively
and extensively with the clinically immune set. Sequence analysis of two of these clones reveals that they are
novel Plasmodium genes.
Immunity to malaria develops gradually, after several at-
tacks and over many years (12). It has long been known that
malaria induces a detectable humoral response in humans. The
successful passive transfer of malarial immunity in human
subjects by means of gamma globulin from immune West
Africans (3) focused attention on the protective nature of at
least some malarial antibodies and implied that humoral
mechanisms constituted a significant effector component of
human immunoresponsiveness. A major thrust in malaria has
thus been to identify these host-protective antibodies and their
target antigens.
An unusual feature of almost all malarial antigens studied to
date is the extensive array of tandemly repeating amino acid
sequences (10). These repeats are immunodominant in the
sense that much of the human antibody response is directed
towards them. It has been observed that many nonimmune
individuals have very high levels of antibodies to many repet-
itive antigens, and it has been suggested that this hyperstimu-
lation of irrelevant B cells leads to a less effective immune
response against critical protective epitopes; thus, the repeats
are acting as a "smokescreen" (1). In addition to the repetitive
epitopes, Plasmodiulm falciparum encodes an enormous num-
ber of cross-reactive epitopes, which are also postulated to be
responsible for immune evasion (1). Therefore, it is desirable
to identify those epitopes which may be protective but are
perhaps obscured by the dominant immune response to the
repetitive and the cross-reactive epitopes.
Screening of P. falciparum expression libraries with immune
sera from protected individuals has been performed earlier,
and a number of antigens have been identified, but indeed,
most of these were found to be antigens containing repetitive
* Corresponding author. Mailing address: Molecular Biology Unit,
Tata Institute of Fundamental Research, Homi Bhabha Road, Bom-
bay 400 005, India. Phone: 091-22-2152971. Fax: 091-22-2152110.
t Present address: Centre For Biotechnology, Jawaharlal Nehru
University, New Delhi 110 067, India.
domains (1, 4, 5, 10). No comparisons between sera from
malaria-susceptible and -immune persons have been made to
date. Thus, in an attempt to target antigenic determinants
which react exclusively with the immune sera, we performed a
differential screening of an expression library of the parasite
with sera from healthy, adult residents of malaria-endemic
areas who had not shown malarial symptoms for at least the
previous 3 years and with sera from malaria patients actively
presenting malarial symptoms at the time of serum collection.
In this article, we present the results of such a screen, which
yielded eight expression clones that react exclusively but
extensively with the immune sera.
MATERIALS AND METHODS
Expression library. The Xgtl 1 cDNA expression library was
a gift from G. N. Godson, New York University Medical
Center. It was constructed from total parasite RNA isolated
from the asexual erythrocytic stages of the FCR-3 strain of P.
falciparum (18).
Sera. (i) Acute-phase patient sera. Thirty serum samples
were collected from patients attending general hospitals in
Surat, Gujarat (western India). Another 12 samples were
obtained from patients visiting malaria clinical centers in
Sonapur, Assam (eastern India). Patient sera were also col-
lected from 23 patients admitted to hospitals in Cuttack,
Phulbani, and Keonjhar, Orissa (eastern India). Five serum
samples were collected from P. falciparum-infected individuals
in Bombay. All of these sera were obtained from smear-
positive individuals of both sexes and include samples collected
from children as well.
(ii) Immune sera. A total of 92 serum samples were obtained
from healthy adult residents of P. falciparuim-endemic areas of
the state of Orissa, India. Of these, 67 samples were collected
from the Phulbani and Keonjhar districts, while 25 serum
samples were collected from a tribal population of the Rour-
kela district. None of these individuals exhibited malarial
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symptoms at the time of serum collection nor had they done so
for the previous 3 to 12 years, as ascertained from an extensive
questionnaire answered by the subjects as well as their records
in the primary health centers. Of the donors, 83% were in the
age group of 25 to 50 years, 4% were younger than 25 years,
and 13% were older than 50 years. The percentages of male
and female donors were 54% and 46%, respectively. About
67% of the donors had not had an attack of malarial fever for
the previous 5 to 10 years, whereas 25% showed an absence of
attack for the previous 3 to 5 years. The remaining 8% had
been immune to malaria for more than 10 years. The blood
samples of all of the immune adults were tested for P.
falciparum at the time of collection, and only 2 of the 94 donors
were found to be smear positive, with low levels of parasitemia.
Both of these samples were collected from the Rourkela
district.
All sera were extensively purified of anti-Escherichia coli
antibodies by several cycles of absorption with filter lifts of
wild-type Xgtll on Y1090 and used at a dilution of 1:100.
Immunological screening of the library. Immunological
screening was done essentially by the method of Young and
Davis (23). Briefly, 10,000 plaques were plated on each 87-mm
NZ plate, and the plates were incubated at 42°C for 4 h and
then at 37°C for 2 h. Isopropyl-4-D-thiogalactopyranoside(IPTG)-saturated filters were then placed on the phage to
induce the expression of the fusion proteins and left standing
overnight. The filters were blocked in 5% nonfat milk for 1 h.
They were incubated in the E. coli-adsorbed immune human
sera (diluted 1:100) at 4°C for 16 h. After the filters were
washed in Tris-buffered saline-Tween, they were incubated
with goat anti-human immunoglobulin G conjugated to horse-
radish peroxidase (Cappel, Organon Teknika, Durham, N.C.)
for 1 h. These filters were then extensively washed, and positive
reactions were detected by using diaminobenzidine and hydro-
gen peroxide as substrates. Immunoreactive plaques were
purified to homogeneity by two to three cycles of infection with
Y1090 and plating for single plaques as described above.
Immunodot blots of phage. Plaques which were positive with
the immune sera were spotted in a grid on a lawn of Y1090.
They were grown and induced as described above. The filters
were then treated with the respective serum samples, and
immunoreactivities were visually scored on a scale of - to
+ + + in increasing order of signal intensity.
ELISA. The enzyme-linked immunosorbent assay (ELISA)
used for the determination of serum reactivity among immune
serum samples was performed as follows. An asynchronous
culture of parasite strain FCR-3 was harvested at a parasitemia
of about 8%, and the parasite pellet was obtained by saponin
lysis (24). The pellet was sonicated for 3 min in 0.15 M
phosphate-buffered saline (PBS; pH 7.4). Two hundred micro-
liters of a 5-pRg/ml solution of the extract described above was
added to microtiter plates (Maxisorp; Nunc, Roskilde, Den-
mark) and left standing overnight at 4°C. After being washed
with 0.05% (vol/vol) Tween 20 in PBS (PBST), the plates were
coated with 200 [L of PBST containing 7% sheep serum for 1
h at 37°C. All subsequent steps were carried out at 37°C. The
wells were incubated for 2 h with 200 RI of 20 random samples
of immune sera from the Keonjhar and Phulbani districts,
diluted 1:100 in PBST. After extensive washing of the wells
with PBST, the binding of serum antibodies was detected with
horseradish peroxidase-conjugated anti-human immunoglobu-
lin G (Cappel), diluted 1:2,000 in PBST for 1 h. After the wells
were washed three times with PBST, 200 ,ul of substrate
solution [10 mg of 2,2'-azino-di(3-ethyl-benzylthiozoline)sulfo-
nic acid 6 (ABTS; Boehringer GmbH, Mannheim, Germany)]
in 50 ml of NaHPO4 buffer (pH 4.0), with 125 ,ul of 10% H202,
was dispensed into each well. The color was allowed to develop
for 30 min at room temperature (25 ± 2°C), and the A405
values were read.
Phage DNA preparation and sequencing of the Plasmodium
inserts. Phage DNA was prepared by standard protocols (16).
The DNA was cut with EcoRI, and inserts were sized by using
standard molecular weight markers. The inserts were sub-
cloned into pGEM 3Z(f-) (Promega, Madison, Wis.). Plasmid
sequencing was done by using standard dideoxy chain termi-
nation protocols (17) with Sequenase version 1 from United
States Biochemicals (Cleveland, Ohio) and [35S]dATP from
Amersham (Buckinghamshire, United Kingdom).
Genomic dot blots. Genomic DNA was prepared from the
FCR3-FMG strain of P. falciparum. Parasites were liberated
from infected erythrocytes by saponin lysis (24) and digested in
digestion buffer (10 mM Tris, 10 mM NaCI, 10 mM EDTA,
proteinase K) at 50°C for 18 h. After extensive phenol-
chloroform extractions, the DNA was precipitated with etha-
nol and resuspended at a concentration of 1 pug/pl. DNA
extracted from Drosophila melanogaster was used as the nega-
tive control. DNA was denatured and spotted onto nitrocellu-
lose paper (Hybond-C; Amersham) and probed with the
respective probes labelled with [32P]dATP to a specific activity
of 2 x 108 cpm/,ug and hybridized in a mixture of 50%
formamide, 5 x SSC, 1 x Denhardt's solution, and 200 p,g of
salmon sperm DNA per ml at 45°C for 16 h. (1 x SSC is 0.15
M NaCl plus 0.015 M sodium citrate). The blots were washed
extensively in 0.1 x SSC at 65°C and exposed to Fuji (Tokyo,
Japan) AIF-RX film for 16 to 72 h at - 70°C.
Nucleotide sequence accession numbers. Two cDNA insert
sequences, Pf 4 and Pf 10, have been recorded in the EMBL
data base under accession numbers X71408 and X71409,
respectively.
RESULTS
An ELISA of 20 of the immune serum samples from the
Phulbani and Keonjhar districts was performed to determine
serum reactivity of this set of serum samples. Two serum
samples, with the highest absorbance values (0.47 and 0.42,
respectively), were pooled and used to screen the P. falciparum
cDNA Xgtll library. Approximately 100 positives were se-
lected from 20,000 plaques for subsequent differential screen-
ing. Of these, 65 clones with distinct positive signals for the
immune sera persisted. These were then subjected to a screen-
ing with 47 patient serum samples in pooled lots. The results of
this immunoscreening are shown in Table 1. Ten of these
clones (subsequently designated Pf 1 to Pf 10) did not react
with any of the patient sera, while the other 55 clones reacted
with the patient sera in different ways. The 10 clones were then
plaque purified and rechecked for nonreactivity with the
patient sera (Table 2). All 10 clones remained nonreactive with
these sera after plaque purification. Another 23 serum samples
from malarial patients living in the same endemic region as the
donors of the immune sera were used for further screening,
and 2 of the 10 clones showed positive reactivities with single
serum samples (Table 2). A representative screening with
patient and immune sera is shown in Fig. 1. In all, 70 patient
serum samples were used to test these clones, and eight of the
expression clones remained nonreactive to this lot.
To have any significance regarding clinical protection, the
epitopes encoded by these clones should be recognized by the
bulk of the immune sera. Table 3 presents the results of such
an analysis, which used 92 serum samples. All clones were
found to react with more than 43% of these samples.
This differential screen was expected to identify novel pro-
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TABLE 1. Serological classification of clones obtained with
different categories of sera
Immunoreactivity with serum samples fromb:
No. of Surat pool Assam
clones' pool General pool Orissa pool
1 2 1 2 (5) (2)
(12)- (18) (6) (6)
4 - - - - - +
5 - - - - - ++
1 - - - - - +++
2 + - + - - ++
1 ++ - ++ - - ++
1 + + + - - +
1 + - + + + +++
1 ++ + ++ + -+++
1 + + + - + ++
1 ++ + ++ - + ++
38 + + + + NDd +
9 ++ ++ ++ ++ ++ ++
a The total number of expression clones tested was 65.
b Immunoreactivity was scored as described in Materials and Methods.
'The number of serum samples used in the pool is shown in parentheses.
d ND, not determined.
tective determinants of P. falciparum. About 2 ,ug of the DNA
from the 10 clones was checked for cross-hybridization with a
pool of nine previously cloned and studied genes of P. falcipa-
rum. These included the S-antigen, MSA-1 (from two strains),
HRP-1, HRP-2, HRP-3, RESA, MESA, and SERA. None of
the 10 clones reacted with probes made from these genes (Fig.
2A). In a control reaction, the same probe was shown to light
up 3.5 ng of the S-antigen DNA.
Inserts of five of the eight differential cDNA clones were
used for cross-hybridization studies with the other clones. No
cross-hybridization was obtained when such a study was per-
formed. This showed that at least five of the eight clones coded
for unique epitopes. A representative blot, using the insert
from Pf 10, is shown in Fig. 2B, where a specific signal is seen
only with DNA from phage Pf 10.
TABLE 2. Reactivity of the 10 Agtll clones with patient sera
Serum category I¶eac;tLvity or ri cione-
(no. of samples) 1 2 3 4 5 6 7 8 9 10 PCb NC'
Pools of patient .+ +
sera from
Assam and
Surat and
general
pool"
Individual
serum
samples
Assam (3) - - - - - - - - - - + +
Surat (15) - - - - - - -. +
Orissa (18) - - - - - - - - - -
Orissa (3) - - - - - - - - - --
Orissa (1) - - - -+
Orissa (1) - - - - +----
1
A B
FIG. 1. A representative picture of the immunoscreening of the 10
Agtl 1 clones with a pool of two immune serum samples (A) and a pool
of 14 patient serum samples, 6 from Assam, and 8 from Surat (B). The
plaques were grown in the following order from left to right: row 1, Pf
1 to 4; row 2, Pf 5 to 8; row 3, Pf 9, 10, PC (a clone which reacted
extensively with most of the patient as well as immune sera), and Agtll.
When sequenced, two of the cDNA clones, Pf 4 and Pf 10,
revealed open reading frames of 238 and 531 bp in frame with
lacZ of Xgtll (Fig. 3 and 4). The A+T contents of Pf 4 and Pf
10 inserts were 71 and 54%, respectively. The sequences were
analyzed by the FASTA program of GenBank (13) to check for
homologies to other known sequences. They both appear to be
novel sequences with no significant homologies with any of the
known genes of P. falciparum or with any other gene from
other organisms. Clone 4 was reported to have a slight
homology to the KAHRP of P. falciparum. The FASTA score
for this homology was 85. Neither clones showed any repeat
sequences, either overt or cryptic, when put through the dot
plot program. A genomic dot blot shows a specific hybridiza-
tion of the insert of clone 10 to the DNA from the FCR3-FMG
strain of P. falciparum (Fig. 2C). The same result was obtained
with the inserts of clones 9, 4, and 2 (data not shown), thus
confirming that these four clones indeed have a P. falciparum
origin. A Southern blot analysis revealed that at least two of
the clones, Pf 4 and Pf 3, were not the same genes, as they
hybridized to different bands in the genomic blot (8a).
A protein homology search was performed on the predicted
amino acid sequences by using the FASTA program with these
two sequences and the EMBL data bank (13). The only
significant matches observed for Pf 4 and Pf 10 are shown in
Fig. 5. Pf 4 showed 53.8% identity in a 52-amino-acid overlap,
with the 60S ribosomal phosphoprotein P0 of human origin,
while Pf 10 showed about 30% identity over a 30-amino-acid
overlap with the M2 matrix protein of influenza virus of various
TABLE 3. Percent reactivity of the 10 Agtll clones with the
immune sera
% of serum samples reacting with clone
Expression
clone no. From Phulbani and From Rourkela Total
Keonjhar (67)a (25) (92)
Pf 1 58 52 57
Pf2 57 60 58
Pf 3 46 35 43
Pf 4 88 85 87
Pf 5 60 80 65
Pf 6 51 50 50
Pf 7 63 40 57
Pf 8 63 45 58
Pf9 69 63 67
Pf 10 66 63 65
a The total number of serum samples tested is shown in parentheses. Each
serum sample was tested individually as described in Materials and Methods.
a Reactivity was scored as described in Materials and Methods.
b PC, positive control (a recombinant expression clone that reacted with most
sera).
c NC, negative control of Agtll phage.
d As described in Table 1.
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FIG. 2. (A) DNA from the 10 Xgtl1 clones probed with a pool of
nine known genes of P. falciparum. The probe consisted of 50 ng of
each of the plasmid DNAs containing the following antigens: S-antigen
(8), MESA (6), RESA (7), MSA-1 (Camp strain), MSA-1 (FC27
strain) (20), KAHRP (19), HRP-11 and HRP-111 (22), and SERA
(21). Two micrograms of each Pf clone DNA was loaded in the
following order from left to right: row 1, Pf 1 to 5; row 2, Pf 6 to 10; row
3, S-antigen (3.5 ng; column c) and Xgtll (2 ,ug; column d). In row 3,
the positions in columns a, b, and e were left empty. (B) The same blot
as that of panel A but probed with the insert of clone Pf 10. (C) Blots:
1, 2 ,ug of Drosophila Schneider cell DNA; 2 and 3: 1 and 0.5 jig,
respectively, of genomic DNA from the FCR3-FMG strain of P.
falciparum probed with the insert of clone Pf 10.
origins. Pf 10 also showed a 17% identity in a 126-amino-acid
overlap with the major capsid protein of varicella-zoster virus
(data not shown).
DISCUSSION
This study describes an attempt to isolate novel, putative
protective antigens of P. falciparum. As shown in Table 1, 47 of
65 expression clones reacted with all sets of serum samples
tested. These, therefore, encode epitopes that are possibly the
immunodominant and cross-reactive epitopes of P. falciparum
(4, 10). There were eight clones that reacted with certain pools
and not with others. These may be antigenically diverse
epitopes of P. falciparum, the positive responses indicating
common molecular epitopes between the FCR-3 strain and
certain Indian strains. However, the differential responses of
these eight clones are more likely to be due to the differential
immune response of individuals since no definitive correlation
was observed for sera obtained from a particular locality. The
possibility of antigenic diversity, or a genetically restricted
immune response causing the exclusive reaction of the 10
clones with the immune sera collected from Orissa, was
eliminated by the use of a set of patient serum samples from
the same endemic area, i.e., Orissa (Table 2). Two determi-
nants, Pf 5 and Pf 6, were indeed found to react with single
serum samples obtained from patients from Orissa. These may
be the candidates for antigenically diverse epitopes. However,
eight of the expression clones did not react with any of the 70
patient serum samples tested, whereas they were immunopo-
sitive with at least 43% of the 92 immune serum samples tested
(Table 3).
Approximately 40 genes coding for various surface antigens
of P. falciparum have been cloned and sequenced at least in
part. Many of them have been isolated by screening expression
libraries with clinical sera or monoclonal antibodies (1, 4, 5, 9,
10). This study shows that the differential serological screen
that we employed resulted in the identification of 10 expression
clones that were different from nine common antigens of P.
falciparum (Fig. 2A). Further analysis showed that two of these
are indeed novel epitopes, without any repetitive regions (Fig.
3 and 4). Pf 4 is of special interest because it is the most widely
occurring epitope among the immune serum samples. At-
tempts to affinity purify the specific antibody corresponding to
the clones Pf 4 and Pf 10 and subsequently detect the parasite
antigen on a Western blot (immunoblot) met with limited
success (hla). It is possible that the antigens may be minor
constituents of the parasite proteins or may be transitionally
expressed epitopes. The ,3-galactosidase fusion proteins from
the original Agtll clones, as well as other fusion proteins of
these epitopes constructed in other expression systems in E.
coli, were found to be unstable.
It is possible that, in such a differential screen, we are
missing certain epitopes that may be relevant to protection. It
is known that adults of endemic area are often protected. Some
12 24 36 48 60
GAA TTC CTT TTT CGC GCA TTG TTC CCA TTA TAT TTT AAT TTA AAT ATT ATT TTA TTT TTT
Glu Phe Leu Phe Arg Ala Leu Phe Pro Leu Tyr Phe Asn Leu Asn Ile Ile Leu Phe Phe
72 84 96 108 120
AAA AAA AAG GCG AAA TTA TCC AAG CAA CAA AAA AAG CAA ATG TAC ATT GAG AAG CTT AGC
Lys Lys Lys Ala Lys Leu Ser Lys Gln Gln Lys Lys Gln Met Tyr Ile Glu Lys Leu Ser
132 144 156 168 180
TCT CTC ATT CAA CAA TAT TCC AAA ATA TTA ATT GTG CAT GTA GAC AAT GTG GGA TCT AAT
Ser Leu Ile Gln Gln Tyr Ser Lys Ile Leu Ile Val His Val Asp Asn Val Gly Ser Asn
192 204 216 228 240
CAA ATG GCT AGT GTT CGT AAA AGT TTA AGA GGA AAG GCT ACA ATA TTG ATG GGA AAA AAT
Gln Met Ala Ser Val Arg Lys Ser Leu Arg Gly Lys Ala Thr Ile Leu Met Gly Lys Asn
ACA AGA ATT C
Thr Arg Ile
FIG. 3. Nucleotide and predicted amino acid sequences of the entire cDNA insert of Pf 4 encoding an open reading frame of 250 bp, starting
and ending with the Xgtll EcoRI sites.
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24
AAC GCG TTG GGA
Asn Ala Leu Gly
36 48
GOCT CAT CGC AAA ATT TTT
Ala His Arg Lys Ile Phe
60
CAG GCC TAC AGA
Gin Ala Tyr Arg
72 84 96
TTA TTG ACG ATG CGA GTT TTC TAC CAA
Lou Leu Thr Met Arg Val Phe Tyr Gln
108 120
ATT ATG AAT ATG CTG CTG CGT ATT
Ile Met Asn Met Leu Leu Arg Ile
144
TTC CAC TGT ATT CCA TTT
Phe His Cys Ile Pro Phe
156 168
TTC GGA TCA GAC CAT
Phe Gly Ser Asp His
180
CAT CAG TTT TTC
His Gin Phe Phe
204
TGT TTT ATT TTT GGT
Cys Phe Ile Phe Gly
264
CCT CAG GAT ACT GTT
Pro Gln Asp Thr Val
324
TTA TGT ACG CAA TCA
Leu Cys Thr Gln Ser
216
CCT CCA
Pro Pro
276
TCT TTG
Ser Leu
3386
TGC TTC
Cys Phe
384 396
TCT GTG GCA CAT CTC CTT GCA
Ser Val Ala His Leu Leu Ala
444
CTA CTG GGC TGC TTC
Leu Leu Gly Cys Phe
504
GGC CGC ACT AGT GAT
Gly Arg Thr Ser Asp
228 240
TAC CAT TCT TCG GAT CAG ATC ATC
Tyr His Ser Ser Asp Gln Ile Ile
288 300
TCT TTT AGA CAT TCT TTG AAC ATC
Ser Phe Arg His Ser Leu Asn Ile
348 360
TGC CAT GCC TAT GCA CGG CTG TAT
Cys His Ala Tyr Ala Arg Leu Tyr
408 420
TGC ACA TTC TTG CTG CTG CGT GCT
Cys Thr Phe Leu Leu Leu Arg Ala
456 468
CTA ATG CAG AGT CGC ATA
Leu Met Gin Ser Arg Ile
516 528
ATC CCA CAT GGC GGC CGG
Ile Pro His Gly Gly Arg
480
AGG GAT GAC TGT
Arg Asp Asp Cys
540
GAG CAT GCA GAA
Glu His Ala Glu
TTC
Phe
FIG. 4. Nucleotide and predicted amino acid sequences of the entire cDNA insert of Pf 10 encoding an open reading frame of 543 bp, starting
and ending with the Xgtll EcoRI sites.
of the patient serum samples used in our screening were
obtained from adults living in an endemic area and may
contain antibodies against epitopes that are important for
protection. Indeed, serum samples that reacted with Pf5 and
Pf6 might belong to this category.
This differential screen was designed to isolate expression
clones of P. falciparum against which antibodies were present
only in malaria-immune persons, and therefore, they may be
putative protective antigens. However, these immune persons
have been exposed to repeated attacks of malaria, and thus it
was anticipated that along with antibodies relevant for the
immune response, there may be antibodies against nonsurface
proteins as well. Especially, autoantibodies against protein
domains of P. falciparum which are conserved between humans
and parasites may be raised in such a set of immune persons.
If Pf 4 turns out to be the P. falciparum equivalent for the
ribosomal protein P., it would belong to such a class of protein
domain. To date, only the amino acid sequence of the human
P0 phosphoriboprotein is available (15), and therefore it is
difficult to predict whether this homologous domain is con-
served in all organisms. It would, nevertheless, be important to
characterize this protein of P. falciparum since ribosomes form
a prime target for drugs.
The matrix protein M2 of the influenza virus is a protein that
is expressed abundantly on the infected cell surface (11). M2 is
a type III membrane protein with 24 N-terminal residues in the
lumen, 54 residues in the cytosol, and a single membrane-
spanning segment (11). The homology of M2 with Pf 10 starts
from the membrane-spanning domain and continues in the
cytosolic domain. M2 has recently been shown to be an
(A)
10 20 30 40 50 60
Pf4 FLFRALFPLYEMLNIILFFKKKAKLSKQQKKQMYIEKLSSLIQQYSKILIVHVDNVGSN
: :. :. :...:.: .X: .:::::.
HuPo MPREDRATWKSNYFLKI IQLLDDYPKCFIVGADNVGSK
70 80
Pf4 QMASVRKSLRGKATILMGKNT
HuPo QMQQIRMSLRGKAVVLMGKNT
(B)
Pf 10
M2H/U
M2H/B
M2H/P
M2A/F
M2A/M
Pf 10
M2H/U
M2H/B
M2H/P
M2A/F
M2A/M
10 20 30 40 50
SYASNALGAHRKIFQAYRDAPLLTMRVFYQIMNMLLRIPNVIIFHCI-PFF
X:.. . : .... :.: . ..:.:X .::
MSLLTEVETPIRNEWGCRCNDSSDPLVVAASIIGILHLI LWI LDRLFFKCIYRFF
10 20 30 40 50
G AI N
T G E II
T G E K I
60 70 80 90
GSDHHQFFSTSGYCFIFGPPYHSSDQIITNFLVPQDTVSLSF
......
EHGLKRGPSTEGVPESMREEYRKEQQSAVDADDSHFVSIELE
60 70 80 90
K
KY G
KY
KY
K
R
RL
RL
G
Q V G N
Q V G N
FIG. 5. (A) The homology observed between the protein coded by
Pf 4 and the human 60S ribosomal phosphoprotein PO (15). (B) The
predicted homology between the protein coded by Pf 10 and the M2
proteins from different strains of influenza A virus. H/U, H/B, and H/P
are three strains of human influenza virus, while A/F and A/M are
avian strains (2). These homologies were determined by using the
FASTA program (13), and X's denote the ends of the initial region
found by FASTA.
GAA TTC AGC
Glu Phe Ser
12
TAT GCA TCC
Tyr Ala Ser
GAT GCG CCG
Asp Ala Pro
CCA AAT GTA
Pro Asn Val
132
ATA ATA
Ile Ile
TCA ACA TCA
Ser Thr Ser
ACC AAT TTT
Thr Asn Phe
ACA GTG CCG
Thr Val Pro
ACT GTA GAT
Thr Val Asp
CAC GTC CTC
His Val Leu
CGA CCT GCA
Arg Pro Ala
192
GGA TAC
Gly Tyr
252
TTA GTA
Leu Val
312
TCG TTG
Ser Leu
372
TGT GCA
Cys Ala
432
AAC CTA
Asn Leu
492
GGC GGC
Gly Gly
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amantadine-sensitive ion channel for monovalent cations (14).
Further characterizations of Pf 10 will determine whether it
plays an equivalent role in P. falciparum.
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